

Daiichi Sankyo India Pharma Profile
Key Indicators
- Authorised Capital ₹ 178.00 Cr
- Paid Up Capital ₹ 177.00 Cr
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2016
- Revenue Growth 3.15%
- Profit Growth 7.27%
- Ebitda -7.13%
- Net Worth 10.37%
- Total Assets 10.64%
About Daiichi Sankyo India Pharma
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233HR2007PTC044362
- Company No.
044362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2007
- Date of AGM
28 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Daiichi Sankyo India Pharma?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Takashi Mochizuki ![]() | Director | 01-Jul-2017 | Current |
Velloor Ranganathan ![]() | Director | 01-Jul-2017 | Current |
Masahiko Otsuki ![]() | Director | 12-Aug-2010 | Current |
Financial Performance of Daiichi Sankyo India Pharma.
Daiichi Sankyo India Pharma Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 3.15% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth Soared by an impressive increase of 10.37%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Daiichi Sankyo India Pharma?
In 2016, Daiichi Sankyo India Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Brigade Enterprises Limited
Velloor Ranganathan is a mutual person
- Bharti Axa Life Insurance Company Limited
Velloor Ranganathan is a mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Daiichi Sankyo India Pharma?
Unlock and access historical data on people associated with Daiichi Sankyo India Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Daiichi Sankyo India Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daiichi Sankyo India Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Daiichi Sankyo India Pharma
Recent activity within the organization
- Director Appointment
Velloor Venkatakrishnan Ranganathan was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 7 years 7 months .
01 Jul 2017
- Director Appointment
Takashi Mochizuki was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 7 years 7 months .
01 Jul 2017
- Annual General Meeting
Daiichi Sankyo India Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2016 as per latest MCA records.
28 Sep 2016
- Balance Sheet
Daiichi Sankyo India Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi.
31 Mar 2016
- Director Appointment
Masahiko Otsuki was appointed as a Director was appointed as a Director on 12 Aug 2010 & has been associated with this company since 14 years 6 months .
12 Aug 2010
- Company Incorporation
Daiichi Sankyo India Pharma Private Limited was registered on 13 Mar 2007 with Roc Delhi & aged 17 years 11 months as per MCA records.
13 Mar 2007
Frequently asked questions
What is the Incorporation or founding date of Daiichi Sankyo India Pharma Private Limited?
Daiichi Sankyo India Pharma Private Limited was incorporated on 13 Mar 2007.
What is authorized share capital and paid-up capital of Daiichi Sankyo India Pharma Private Limited?
The authorized share capital of Daiichi Sankyo India Pharma Private Limited is ₹ 178.00 Cr and paid-up capital is ₹ 177.00 Cr.
Who are the current board members & directors of Daiichi Sankyo India Pharma Private Limited?
Currently 3 directors are associated with Daiichi Sankyo India Pharma Private Limited.
- Velloor Venkatakrishnan Ranganathan
- Masahiko Otsuki
- Takashi Mochizuki
What is the registered address of Daiichi Sankyo India Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Daiichi Sankyo India Pharma Private Limited is Unit 62 Level 18 One Horizon Center Golf Course Road Dlf Phase 5, Sector-4 3 India, Gurgaon, Haryana, 122002.
What is the corporate identification number (CIN) and company number of Daiichi Sankyo India Pharma Private Limited?
The corporate identification number (CIN) of Daiichi Sankyo India Pharma Private Limited is U24233HR2007PTC044362 and the company number is 044362 as per Ministry of Corporate Affairs (MCA).
What is the official website of Daiichi Sankyo India Pharma Private Limited?
The Official website of Daiichi Sankyo India Pharma Private Limited is https://www.dsin.co.in
What has been the recent revenue trend for Daiichi Sankyo India Pharma Private Limited?
According to the financial reports for the fiscal year 2015, the revenue trend for Daiichi Sankyo India Pharma Private Limited has risen by 3.15%.
What change has been observed in the net worth of Daiichi Sankyo India Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2015 indicates that The net worth of Daiichi Sankyo India Pharma Private Limited has experienced an upsurge of 10.37%.
When was the last Balance Sheet of Daiichi Sankyo India Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Daiichi Sankyo India Pharma Private Limited was filed with the ROC on 31 Mar 2016.
People also Viewed
- Vandana ShroffDirector
- Jay SomanDirector
- Brinda DuttaDirector
- Hiroyuki OkuzawaDirector
- Koichi AkahaneDirector
- Takahide NishiDirector
- Yoshio UchidaDirector
- Venugopal VijayendranAlternate Director
Similar Companies Based on Accounting and Financial Analysis
- Relx India Private Limited New Delhi, Delhi, India
- Penguin Random House India Private Limited Delhi, India
- Mahindra Integrated Business Solutions Private Limited Mumbai, Maharashtra, India
- Kpmg Global Delivery Center Private Limited Bangaluru, Karnataka, India
- Deloitte Touche Tohmatsu India Llp Mumbai, Maharashtra, India
- Deloitte Haskins & Sells Llp Mumbai, Maharashtra, India
- Lokmat Media Private Limited Mumbai, Maharashtra, India
- American Express(India) Private Limited New Delhi, Delhi, India